How to Identify A Fake 2mg Yellow Xanax R039 Pill
Real R 0 3 9 Xanax Bar is a yellow, rectangle pill that has been identified as containing alprazolam 2 mg. Original R 0 3 9 Xanax Bars are supplied by Actavis. Alprazolam is used in the treatment of anxiety and panic disorder, it belongs to the drug class benzodiazepines. Alprazolam 2 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
There has been a proliferation of fake and adulterated R039 Xanax pills. The fake pills also have R039 printed on one side and have three line breaks delineating four sections. The identification of a range of different drugs within counterfeit benzodiazepine tablets has also been widely reported.
Drug dealers are now producing fake 2mg dark yellow Xanax, R039 laced with Fentanyl. This is because it takes very little to produce a high with fentanyl, making it a cheaper option. This is especially risky when people taking drugs don’t realize they might contain fentanyl as a cheap but dangerous additive. They might be taking stronger opioids than their bodies are used to and can be more likely to overdose.
Fentanyl is a powerful synthetic opioid that is similar to morphine but is 50 to 100 times more potent. Mortalities due to fentanyl derivatives are on the rise with novel fentanyl analogs wreaking havoc on a global scale. They are highly potent and very fatal in low doses. According to the CDC, nearly 841,000 people have died since 1999 from a drug overdose. In 2019, 70,630 drug overdose deaths occurred in the United States. The age-adjusted rate of overdose deaths increased by over 4% from 2018 (20.7 per 100,000) to 2019 (21.6 per 100,000).
How to Spot Fake 2mg Yellow R039 Xanax Bars
In their latest report on fake online pharmacies that ply their trade in the United States, the National Association of Boards of Pharmacy (NABP) found more than 1,500 new websites that it considers “Not Recommended,” and of these, 31% are offering illicit prescription drugs. Studies have shown that poor quality medicines represent a global threat to public health that can result in treatment ineffectiveness, drug resistance, increased morbidity and mortality rate, economic loss, and problems to the healthcare system.
As a consumer, you may not have access to most of the test equipment used by regulatory bodies to verify the identity of a drug product. The following tips will serve as a guide to purchasing genuine R039 yellow Xanax bars pills and NOT a fake R039 pill pressed and sold by a fake drug cartel;
Visual inspection as stated by the World Health Organization (WHO) (1999) still remains the first step in identifying potential fake drug irrespective of the analytical methods used. This is because such observation serves as a lead to identifying fake products even in the absence of the knowledge of the physical characteristics of a genuine drug product. You are expected to examine carefully both the package and its content before purchase or use.
Visual inspection of the Package
- Examine the package and check if it appears suspicious or different from what you previously know.
- Check if the security seal has been tampered with by looking for breaks or tears in the sealing tape and seals.
- Look for unusual fonts, font sizes, print color, and spelling errors.
- Check the legibility of the information on both the primary and secondary packages.
- Check if the batch number, expiry date and manufacturer’s address on the secondary package are the same with that on the primary package.
- Check if the manufacturer’s address is traceable, that is, if it contains the exact location of the company and not just the country address.
- Check if the registration number (FDA number as the case is for products marketed or sold in United States) is properly printed or if it appears to be tampered with.
Visual inspection of the Dosage form
At this stage, you are meant to check for differences in the physical appearance (color uniformity, size, shape, consistency, etc.) of the drug. As stated by WHO, commonly encountered physical defects that should be looked out for in tablets include:
- Excessive powder and/or pieces of tablets at the bottom of the container (from abraded, crushed or broken tablets).
- Cracks or chips in the tablets, swelling, mottling, discolouration, fusion of tablets.
- Appearance of crystal on the walls of the container or on the tablet.
- Hardening or softening, cracking, swelling, mottling or discolouration of capsule shell should also be looked out for.
The source of the drug also determines if you are buying a fake yellow Xanax bar or not. Buying Mexican R039 yellow Xanax bars exposes you to a lot of risks. Filling your prescription in a reputable pharmacy greatly reduces your chances of buying fake drugs while buying from illiterate and unqualified vendors who hawk drugs in buses, motor parks, and in the streets increases your chances of buying fake drugs.
This is another way of identifying fake R039 yellow Xanax bars. If the price is far cheaper than what is expected, then you have to think twice. However, this may not always be true, especially for some products (fake innovator/generic brands) which may be sold at the same price as the genuine ones.
Unexpected side effect
Counterfeit yellow Xanax bars most of the time contain substances other than the appropriate Active Pharmaceutical Ingredient (API). They may contain incorrect substances, improper dosage, or hazardous substances like Fentanyl which produce unusual side effects, worsening medical conditions after taking it. The medication should be stopped once any of the above is noticed.
Fentanyl Test Fentanyl testing is one of the most reliable ways of telling a fake from a real R039 yellow Xanax bar. A new University of Maryland study found fentanyl tops the list of drugs detected in overdose patients at two Baltimore hospital emergency departments. The finding suggests that hospitals and medical systems throughout the United States consider adding fentanyl, a potent synthetic opioid linked to most fatal overdoses in Maryland, to their routine drug testing panels. That is the conclusion of researchers at the University of Maryland School of Medicine (UMSOM) and the Center for Substance Abuse.